Eucomed approves procedural framework for code of ethics in the EU
This article was originally published in RAJ Devices
European medical technology industry association Eucomed has approved a procedural framework for ensuring that companies comply with its code of ethics relating to interactions with healthcare providers1,2.
You may also be interested in...
The European Medicines Agency is expected to decide soon whether Amarin’s fish oil pill, Vascepa, should win pan-EU marketing approval for reducing cardiovascular risk.
Karyopharm and GSK should soon learn whether the European Medicines Agency will recommend EU approval for their respective products, selinexor and dostarlimab.
The withdrawal of the marketing authorization application for Dexamethasone Taw as a treatment for COVID-19 patients was revealed today in the January meeting agenda of the European Medicines Agency’s human medicines committee, the CHMP.